Delivery Order SPE2DB22D1017-SPE2DB25FF3WR

Award Date 1/24/25
Potential Completion Date 1/27/25
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,489.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4560287772 - Lidocaine 5% Patch 30s, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 17, 2023. This award is not associated with a set-aside program. AmerisourceBergen...
This federal contract award, valued at $2,482.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Lidocaine 5% Patch 30s, a medical product, to support DLA's Troop Support Medical program. The award has an ultimate completion date of May 9, 2024, and it is a firm fixed-price delivery order contract. This contract is not designated with any set-aside requirements, indicating open...
This federal contract award, valued at $4,359.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of July 23, 2024 and is structured as a Firm Fixed Price Delivery Order with no set-aside designation, indicating open...
This federal contract award, valued at $4,664.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566121260 - Lidocaine 5% Patch 30s, with a completion date of October 17, 2024. The award is a Delivery Order under a Firm Fixed Price contract type. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award, valued at $13,611.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as a prime contractor. The contract is for the delivery of 4564185827 - Lidocaine 5% Patch 30s, a pharmaceutical product, to support military treatment programs and facilities. The contract has a firm fixed price pricing type and a period of performance through April 8, 2024. No set-aside designation was used for this...
This federal contract award, valued at $2,363.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% Patch 30S, a medical supply item, with a completion date of January 31, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $10,247.63, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% Patch 30s, a medical product used for pain management. The contract is a Firm Fixed Price Delivery Order with a period of performance ending on February 26, 2024. The contract was not designated with any set-aside...
This federal contract award, valued at $4,314.31, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4563344441 - Lidocaine 5% Patch 30s, a medical product. This appears to be a firm-fixed-price delivery order contract with a completion date of January 18, 2024. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a...
This federal contract award, valued at $3,556.23, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% Patch 30s, a medical product, and has an ultimate completion date of April 2, 2025. The contract is a Delivery Order under a Firm Fixed Price pricing type. This award is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $5,628.49, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% Patch 30s, a medical product used for pain management. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of December 23, 2024. The contract was not set aside for any specific business type. AmerisourceBergen holds a...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF3WR
    Delivery Order

This federal contract award, valued at $3,022.77, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp. The contract is for the delivery of 4567037780 - Lidocaine 5% Patch 30s, a pharmaceutical product. The contract has an ultimate completion date of January 27, 2025 and is structured as a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, including the military healthcare system. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/21/25, 10:00 AM